ONICKIE LYNCH: Open Payments
NPI 1306321211 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 37 payments from 17 companies in 2025. Trend: 2023 $935 · 2024 $1,130 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $189 |
| Merck Sharp & Dohme LLC | 10 | $176 |
| ANI Pharmaceuticals, Inc. | 2 | $140 |
| ABBVIE INC. | 1 | $118 |
| Gilead Sciences, Inc. | 1 | $116 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $99 |
| Vanda Pharmaceuticals Inc. | 1 | $99 |
| Lilly USA, LLC | 4 | $77 |
| Axsome Therapeutics, Inc. | 1 | $62 |
Products named: BREZTRI, PURIFIED CORTROPHIN GEL, QULIPTA, Yeztugo, XIFAXAN, FANAPT, ZERBAXA, MOUNJARO.
Industry payments across AL — which companies pay providers there.
